nodes	percent_of_prediction	percent_of_DWPC	metapath
Procarbazine—XDH—Oxidative Stress—NOX4—atherosclerosis	0.0193	0.0607	CbGpPWpGaD
Procarbazine—XDH—Purine catabolism—GPX1—atherosclerosis	0.0126	0.0397	CbGpPWpGaD
Procarbazine—XDH—Effects of Nitric Oxide—NOS2—atherosclerosis	0.0121	0.038	CbGpPWpGaD
Procarbazine—Ibuprofen—THBD—atherosclerosis	0.0116	0.418	CrCbGaD
Procarbazine—XDH—Effects of Nitric Oxide—NOS3—atherosclerosis	0.0097	0.0306	CbGpPWpGaD
Procarbazine—CYP1B1—Endogenous sterols—CYP7A1—atherosclerosis	0.00877	0.0276	CbGpPWpGaD
Procarbazine—CYP1B1—Endogenous sterols—CYP27A1—atherosclerosis	0.00811	0.0256	CbGpPWpGaD
Procarbazine—Ibuprofen—PLAT—atherosclerosis	0.00797	0.286	CrCbGaD
Procarbazine—XDH—Oxidative Stress—CYBA—atherosclerosis	0.00764	0.0241	CbGpPWpGaD
Procarbazine—CYP1B1—Arachidonic acid metabolism—LTA4H—atherosclerosis	0.00658	0.0207	CbGpPWpGaD
Procarbazine—XDH—Oxidative Stress—SOD1—atherosclerosis	0.0061	0.0192	CbGpPWpGaD
Procarbazine—XDH—Oxidative Stress—HMOX1—atherosclerosis	0.00587	0.0185	CbGpPWpGaD
Procarbazine—XDH—Oxidative Stress—SOD2—atherosclerosis	0.00549	0.0173	CbGpPWpGaD
Procarbazine—XDH—Oxidative Stress—GPX1—atherosclerosis	0.00524	0.0165	CbGpPWpGaD
Procarbazine—CYP1B1—Estrogen Receptor Pathway—PPARA—atherosclerosis	0.00496	0.0156	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—ALOX5AP—atherosclerosis	0.00491	0.0155	CbGpPWpGaD
Procarbazine—XDH—Purine metabolism—GPX1—atherosclerosis	0.00485	0.0153	CbGpPWpGaD
Procarbazine—CYP1B1—Estrogen Receptor Pathway—ESR1—atherosclerosis	0.00449	0.0142	CbGpPWpGaD
Procarbazine—CYP1B1—Estrogen metabolism—GSTM1—atherosclerosis	0.00441	0.0139	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—ALOX5—atherosclerosis	0.00417	0.0131	CbGpPWpGaD
Procarbazine—CYP1B1—Arachidonic acid metabolism—ALOX15—atherosclerosis	0.00413	0.013	CbGpPWpGaD
Procarbazine—CYP1B1—Arachidonic acid metabolism—ALOX5AP—atherosclerosis	0.00413	0.013	CbGpPWpGaD
Procarbazine—Photosensitivity—Pravastatin—atherosclerosis	0.00412	0.00629	CcSEcCtD
Procarbazine—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	0.00407	0.0128	CbGpPWpGaD
Procarbazine—Vascular purpura—Pravastatin—atherosclerosis	0.00404	0.00617	CcSEcCtD
Procarbazine—Deafness—Pravastatin—atherosclerosis	0.00404	0.00617	CcSEcCtD
Procarbazine—CYP1B1—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	0.00402	0.0127	CbGpPWpGaD
Procarbazine—Haemolytic anaemia—Pravastatin—atherosclerosis	0.00401	0.00612	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—AHR—atherosclerosis	0.00385	0.0121	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—AHR—atherosclerosis	0.00385	0.0121	CbGpPWpGaD
Procarbazine—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.00385	0.00588	CcSEcCtD
Procarbazine—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.00381	0.00582	CcSEcCtD
Procarbazine—Jaundice—Rosuvastatin—atherosclerosis	0.00379	0.00579	CcSEcCtD
Procarbazine—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.00377	0.0119	CbGpPWpGaD
Procarbazine—Purpura—Pravastatin—atherosclerosis	0.00375	0.00573	CcSEcCtD
Procarbazine—CYP1B1—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.00372	0.0117	CbGpPWpGaD
Procarbazine—Haematuria—Rosuvastatin—atherosclerosis	0.00371	0.00566	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—MPO—atherosclerosis	0.00369	0.0116	CbGpPWpGaD
Procarbazine—Ibuprofen—CXCL8—atherosclerosis	0.00367	0.132	CrCbGaD
Procarbazine—XDH—Selenium Micronutrient Network—LDLR—atherosclerosis	0.00367	0.0116	CbGpPWpGaD
Procarbazine—Eosinophilia—Lovastatin—atherosclerosis	0.00366	0.00559	CcSEcCtD
Procarbazine—Pancreatitis—Lovastatin—atherosclerosis	0.00362	0.00553	CcSEcCtD
Procarbazine—Diplopia—Pravastatin—atherosclerosis	0.00362	0.00552	CcSEcCtD
Procarbazine—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.0036	0.0055	CcSEcCtD
Procarbazine—Eosinophilia—Ezetimibe—atherosclerosis	0.00359	0.00548	CcSEcCtD
Procarbazine—Pancreatitis—Ezetimibe—atherosclerosis	0.00355	0.00543	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—F7—atherosclerosis	0.00355	0.0112	CbGpPWpGaD
Procarbazine—CYP1B1—Arachidonic acid metabolism—ALOX5—atherosclerosis	0.00351	0.0111	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—SCARB1—atherosclerosis	0.00343	0.0108	CbGpPWpGaD
Procarbazine—Eosinophilia—Simvastatin—atherosclerosis	0.00342	0.00523	CcSEcCtD
Procarbazine—Pancreatitis—Simvastatin—atherosclerosis	0.00339	0.00518	CcSEcCtD
Procarbazine—Photosensitivity reaction—Lovastatin—atherosclerosis	0.00337	0.00515	CcSEcCtD
Procarbazine—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.00331	0.00505	CcSEcCtD
Procarbazine—CYP1B1—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.0033	0.0104	CbGpPWpGaD
Procarbazine—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.00326	0.00497	CcSEcCtD
Procarbazine—Neuropathy peripheral—Lovastatin—atherosclerosis	0.00323	0.00493	CcSEcCtD
Procarbazine—Dysphagia—Niacin—atherosclerosis	0.00317	0.00485	CcSEcCtD
Procarbazine—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.00317	0.00484	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—PLAT—atherosclerosis	0.00316	0.00996	CbGpPWpGaD
Procarbazine—Photosensitivity reaction—Simvastatin—atherosclerosis	0.00316	0.00482	CcSEcCtD
Procarbazine—Jaundice—Ezetimibe—atherosclerosis	0.00315	0.00481	CcSEcCtD
Procarbazine—Arrhythmia—Rosuvastatin—atherosclerosis	0.00312	0.00476	CcSEcCtD
Procarbazine—Eosinophilia—Pravastatin—atherosclerosis	0.00309	0.00473	CcSEcCtD
Procarbazine—Angina pectoris—Niacin—atherosclerosis	0.00309	0.00472	CcSEcCtD
Procarbazine—Pancreatitis—Pravastatin—atherosclerosis	0.00306	0.00468	CcSEcCtD
Procarbazine—CYP1B1—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.00305	0.00962	CbGpPWpGaD
Procarbazine—Angina pectoris—Pravastatin—atherosclerosis	0.00304	0.00465	CcSEcCtD
Procarbazine—Sweating increased—Pravastatin—atherosclerosis	0.00304	0.00465	CcSEcCtD
Procarbazine—CYP1B1—Melatonin metabolism and effects—EDN1—atherosclerosis	0.00304	0.00959	CbGpPWpGaD
Procarbazine—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00302	0.00461	CcSEcCtD
Procarbazine—Jaundice—Simvastatin—atherosclerosis	0.003	0.00459	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—ABCA1—atherosclerosis	0.00289	0.00911	CbGpPWpGaD
Procarbazine—Photosensitivity reaction—Pravastatin—atherosclerosis	0.00285	0.00436	CcSEcCtD
Procarbazine—Stomatitis—Niacin—atherosclerosis	0.00276	0.00421	CcSEcCtD
Procarbazine—Jaundice—Niacin—atherosclerosis	0.00276	0.00421	CcSEcCtD
Procarbazine—Flushing—Lovastatin—atherosclerosis	0.00275	0.00419	CcSEcCtD
Procarbazine—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00273	0.00417	CcSEcCtD
Procarbazine—Jaundice—Pravastatin—atherosclerosis	0.00272	0.00415	CcSEcCtD
Procarbazine—Sweating—Niacin—atherosclerosis	0.00271	0.00414	CcSEcCtD
Procarbazine—Flushing—Ezetimibe—atherosclerosis	0.00269	0.00411	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—PLG—atherosclerosis	0.00269	0.00847	CbGpPWpGaD
Procarbazine—XDH—Oxidative Stress—NFKB1—atherosclerosis	0.00267	0.00843	CbGpPWpGaD
Procarbazine—Chills—Lovastatin—atherosclerosis	0.00265	0.00405	CcSEcCtD
Procarbazine—Cough—Rosuvastatin—atherosclerosis	0.00265	0.00405	CcSEcCtD
Procarbazine—Alopecia—Lovastatin—atherosclerosis	0.00261	0.00399	CcSEcCtD
Procarbazine—Myalgia—Rosuvastatin—atherosclerosis	0.00259	0.00395	CcSEcCtD
Procarbazine—Arthralgia—Rosuvastatin—atherosclerosis	0.00259	0.00395	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—SOD1—atherosclerosis	0.00258	0.00812	CbGpPWpGaD
Procarbazine—Flushing—Simvastatin—atherosclerosis	0.00257	0.00392	CcSEcCtD
Procarbazine—Alopecia—Ezetimibe—atherosclerosis	0.00256	0.00392	CcSEcCtD
Procarbazine—Haemoglobin—Niacin—atherosclerosis	0.00255	0.0039	CcSEcCtD
Procarbazine—Haemorrhage—Niacin—atherosclerosis	0.00254	0.00388	CcSEcCtD
Procarbazine—Ibuprofen—PPARG—atherosclerosis	0.00254	0.0911	CrCbGaD
Procarbazine—CYP1B1—Estrogen Receptor Pathway—STAT3—atherosclerosis	0.00251	0.00792	CbGpPWpGaD
Procarbazine—Confusional state—Rosuvastatin—atherosclerosis	0.0025	0.00382	CcSEcCtD
Procarbazine—Chills—Simvastatin—atherosclerosis	0.00248	0.00379	CcSEcCtD
Procarbazine—CYP1B1—Melatonin metabolism and effects—APOE—atherosclerosis	0.00248	0.0078	CbGpPWpGaD
Procarbazine—Infection—Rosuvastatin—atherosclerosis	0.00246	0.00376	CcSEcCtD
Procarbazine—Alopecia—Simvastatin—atherosclerosis	0.00245	0.00373	CcSEcCtD
Procarbazine—XDH—Nucleotide metabolism—GPX1—atherosclerosis	0.00244	0.00768	CbGpPWpGaD
Procarbazine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00243	0.00371	CcSEcCtD
Procarbazine—Tremor—Lovastatin—atherosclerosis	0.00241	0.00368	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—APOB—atherosclerosis	0.00238	0.00749	CbGpPWpGaD
Procarbazine—Flushing—Niacin—atherosclerosis	0.00236	0.0036	CcSEcCtD
Procarbazine—Anaemia—Ezetimibe—atherosclerosis	0.00233	0.00356	CcSEcCtD
Procarbazine—Flushing—Pravastatin—atherosclerosis	0.00232	0.00355	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—SOD2—atherosclerosis	0.00232	0.00731	CbGpPWpGaD
Procarbazine—Leukopenia—Lovastatin—atherosclerosis	0.00231	0.00352	CcSEcCtD
Procarbazine—Chills—Niacin—atherosclerosis	0.00228	0.00348	CcSEcCtD
Procarbazine—Arrhythmia—Niacin—atherosclerosis	0.00227	0.00347	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00226	0.00345	CcSEcCtD
Procarbazine—Tremor—Simvastatin—atherosclerosis	0.00226	0.00345	CcSEcCtD
Procarbazine—Alopecia—Niacin—atherosclerosis	0.00225	0.00343	CcSEcCtD
Procarbazine—Chills—Pravastatin—atherosclerosis	0.00224	0.00343	CcSEcCtD
Procarbazine—Insomnia—Rosuvastatin—atherosclerosis	0.00224	0.00343	CcSEcCtD
Procarbazine—Arrhythmia—Pravastatin—atherosclerosis	0.00223	0.00341	CcSEcCtD
Procarbazine—Paraesthesia—Rosuvastatin—atherosclerosis	0.00223	0.0034	CcSEcCtD
Procarbazine—Anaemia—Simvastatin—atherosclerosis	0.00223	0.0034	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—GPX1—atherosclerosis	0.00221	0.00698	CbGpPWpGaD
Procarbazine—Alopecia—Pravastatin—atherosclerosis	0.00221	0.00338	CcSEcCtD
Procarbazine—Cough—Ezetimibe—atherosclerosis	0.0022	0.00337	CcSEcCtD
Procarbazine—Arthralgia—Lovastatin—atherosclerosis	0.00219	0.00335	CcSEcCtD
Procarbazine—Myalgia—Lovastatin—atherosclerosis	0.00219	0.00335	CcSEcCtD
Procarbazine—Anxiety—Lovastatin—atherosclerosis	0.00218	0.00334	CcSEcCtD
Procarbazine—Hypertension—Ezetimibe—atherosclerosis	0.00218	0.00333	CcSEcCtD
Procarbazine—Tension—Niacin—atherosclerosis	0.00217	0.00331	CcSEcCtD
Procarbazine—Leukopenia—Simvastatin—atherosclerosis	0.00216	0.00329	CcSEcCtD
Procarbazine—Myalgia—Ezetimibe—atherosclerosis	0.00215	0.00328	CcSEcCtD
Procarbazine—Arthralgia—Ezetimibe—atherosclerosis	0.00215	0.00328	CcSEcCtD
Procarbazine—Nervousness—Niacin—atherosclerosis	0.00215	0.00328	CcSEcCtD
Procarbazine—Dry mouth—Lovastatin—atherosclerosis	0.00214	0.00327	CcSEcCtD
Procarbazine—Tension—Pravastatin—atherosclerosis	0.00214	0.00326	CcSEcCtD
Procarbazine—Pain—Rosuvastatin—atherosclerosis	0.00212	0.00324	CcSEcCtD
Procarbazine—Constipation—Rosuvastatin—atherosclerosis	0.00212	0.00324	CcSEcCtD
Procarbazine—Confusional state—Lovastatin—atherosclerosis	0.00212	0.00324	CcSEcCtD
Procarbazine—Nervousness—Pravastatin—atherosclerosis	0.00212	0.00323	CcSEcCtD
Procarbazine—Dry mouth—Ezetimibe—atherosclerosis	0.0021	0.00321	CcSEcCtD
Procarbazine—Infection—Lovastatin—atherosclerosis	0.00209	0.00319	CcSEcCtD
Procarbazine—Confusional state—Ezetimibe—atherosclerosis	0.00208	0.00317	CcSEcCtD
Procarbazine—Thrombocytopenia—Lovastatin—atherosclerosis	0.00206	0.00314	CcSEcCtD
Procarbazine—Arthralgia—Simvastatin—atherosclerosis	0.00205	0.00313	CcSEcCtD
Procarbazine—Myalgia—Simvastatin—atherosclerosis	0.00205	0.00313	CcSEcCtD
Procarbazine—Infection—Ezetimibe—atherosclerosis	0.00205	0.00313	CcSEcCtD
Procarbazine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00204	0.00312	CcSEcCtD
Procarbazine—Anxiety—Simvastatin—atherosclerosis	0.00204	0.00312	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—MTHFR—atherosclerosis	0.00204	0.00644	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—LPL—atherosclerosis	0.00204	0.00644	CbGpPWpGaD
Procarbazine—Tremor—Pravastatin—atherosclerosis	0.00204	0.00312	CcSEcCtD
Procarbazine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00203	0.0031	CcSEcCtD
Procarbazine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00202	0.00308	CcSEcCtD
Procarbazine—Anaemia—Pravastatin—atherosclerosis	0.00201	0.00307	CcSEcCtD
Procarbazine—Anorexia—Lovastatin—atherosclerosis	0.002	0.00306	CcSEcCtD
Procarbazine—Syncope—Niacin—atherosclerosis	0.00198	0.00303	CcSEcCtD
Procarbazine—Confusional state—Simvastatin—atherosclerosis	0.00198	0.00303	CcSEcCtD
Procarbazine—Leukopenia—Niacin—atherosclerosis	0.00198	0.00302	CcSEcCtD
Procarbazine—Urticaria—Rosuvastatin—atherosclerosis	0.00197	0.00301	CcSEcCtD
Procarbazine—Oedema—Simvastatin—atherosclerosis	0.00197	0.003	CcSEcCtD
Procarbazine—Abdominal pain—Rosuvastatin—atherosclerosis	0.00196	0.00299	CcSEcCtD
Procarbazine—Infection—Simvastatin—atherosclerosis	0.00195	0.00298	CcSEcCtD
Procarbazine—Leukopenia—Pravastatin—atherosclerosis	0.00195	0.00298	CcSEcCtD
Procarbazine—Loss of consciousness—Niacin—atherosclerosis	0.00194	0.00297	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—CRP—atherosclerosis	0.00194	0.00612	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—CD36—atherosclerosis	0.00194	0.00611	CbGpPWpGaD
Procarbazine—Cough—Niacin—atherosclerosis	0.00193	0.00295	CcSEcCtD
Procarbazine—Thrombocytopenia—Simvastatin—atherosclerosis	0.00192	0.00294	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00191	0.00292	CcSEcCtD
Procarbazine—Insomnia—Lovastatin—atherosclerosis	0.0019	0.0029	CcSEcCtD
Procarbazine—Cough—Pravastatin—atherosclerosis	0.0019	0.0029	CcSEcCtD
Procarbazine—Paraesthesia—Lovastatin—atherosclerosis	0.00189	0.00288	CcSEcCtD
Procarbazine—Arthralgia—Niacin—atherosclerosis	0.00188	0.00288	CcSEcCtD
Procarbazine—Myalgia—Niacin—atherosclerosis	0.00188	0.00288	CcSEcCtD
Procarbazine—Hypertension—Pravastatin—atherosclerosis	0.00188	0.00287	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—APOA1—atherosclerosis	0.00188	0.00592	CbGpPWpGaD
Procarbazine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00188	0.00287	CcSEcCtD
Procarbazine—Anorexia—Simvastatin—atherosclerosis	0.00187	0.00286	CcSEcCtD
Procarbazine—Insomnia—Ezetimibe—atherosclerosis	0.00186	0.00285	CcSEcCtD
Procarbazine—CYP1B1—Arachidonic acid metabolism—GPX1—atherosclerosis	0.00186	0.00587	CbGpPWpGaD
Procarbazine—Myalgia—Pravastatin—atherosclerosis	0.00185	0.00283	CcSEcCtD
Procarbazine—Arthralgia—Pravastatin—atherosclerosis	0.00185	0.00283	CcSEcCtD
Procarbazine—Paraesthesia—Ezetimibe—atherosclerosis	0.00185	0.00283	CcSEcCtD
Procarbazine—Anxiety—Pravastatin—atherosclerosis	0.00185	0.00282	CcSEcCtD
Procarbazine—Dry mouth—Niacin—atherosclerosis	0.00184	0.00281	CcSEcCtD
Procarbazine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00183	0.00279	CcSEcCtD
Procarbazine—Decreased appetite—Lovastatin—atherosclerosis	0.00183	0.00279	CcSEcCtD
Procarbazine—Fatigue—Lovastatin—atherosclerosis	0.00181	0.00277	CcSEcCtD
Procarbazine—Oedema—Niacin—atherosclerosis	0.00181	0.00276	CcSEcCtD
Procarbazine—Constipation—Lovastatin—atherosclerosis	0.0018	0.00274	CcSEcCtD
Procarbazine—Pain—Lovastatin—atherosclerosis	0.0018	0.00274	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—F2—atherosclerosis	0.00179	0.00565	CbGpPWpGaD
Procarbazine—Confusional state—Pravastatin—atherosclerosis	0.00179	0.00274	CcSEcCtD
Procarbazine—Decreased appetite—Ezetimibe—atherosclerosis	0.00179	0.00274	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00179	0.00274	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—ICAM1—atherosclerosis	0.00179	0.00563	CbGpPWpGaD
Procarbazine—Asthenia—Rosuvastatin—atherosclerosis	0.00178	0.00272	CcSEcCtD
Procarbazine—Insomnia—Simvastatin—atherosclerosis	0.00178	0.00272	CcSEcCtD
Procarbazine—Oedema—Pravastatin—atherosclerosis	0.00178	0.00271	CcSEcCtD
Procarbazine—Fatigue—Ezetimibe—atherosclerosis	0.00178	0.00271	CcSEcCtD
Procarbazine—Shock—Niacin—atherosclerosis	0.00178	0.00271	CcSEcCtD
Procarbazine—Infection—Pravastatin—atherosclerosis	0.00177	0.0027	CcSEcCtD
Procarbazine—Paraesthesia—Simvastatin—atherosclerosis	0.00177	0.0027	CcSEcCtD
Procarbazine—Pain—Ezetimibe—atherosclerosis	0.00176	0.00269	CcSEcCtD
Procarbazine—Constipation—Ezetimibe—atherosclerosis	0.00176	0.00269	CcSEcCtD
Procarbazine—Tachycardia—Niacin—atherosclerosis	0.00176	0.00269	CcSEcCtD
Procarbazine—Pruritus—Rosuvastatin—atherosclerosis	0.00175	0.00268	CcSEcCtD
Procarbazine—CYP1B1—Biological oxidations—CYP7A1—atherosclerosis	0.00175	0.00553	CbGpPWpGaD
Procarbazine—Hyperhidrosis—Niacin—atherosclerosis	0.00175	0.00266	CcSEcCtD
Procarbazine—Thrombocytopenia—Pravastatin—atherosclerosis	0.00174	0.00266	CcSEcCtD
Procarbazine—Feeling abnormal—Lovastatin—atherosclerosis	0.00173	0.00264	CcSEcCtD
Procarbazine—CYP1B1—Metapathway biotransformation—CYP7A1—atherosclerosis	0.00173	0.00545	CbGpPWpGaD
Procarbazine—Anorexia—Niacin—atherosclerosis	0.00172	0.00263	CcSEcCtD
Procarbazine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00172	0.00262	CcSEcCtD
Procarbazine—Hyperhidrosis—Pravastatin—atherosclerosis	0.00172	0.00262	CcSEcCtD
Procarbazine—Decreased appetite—Simvastatin—atherosclerosis	0.00171	0.00261	CcSEcCtD
Procarbazine—Feeling abnormal—Ezetimibe—atherosclerosis	0.0017	0.00259	CcSEcCtD
Procarbazine—Diarrhoea—Rosuvastatin—atherosclerosis	0.0017	0.00259	CcSEcCtD
Procarbazine—Fatigue—Simvastatin—atherosclerosis	0.00169	0.00259	CcSEcCtD
Procarbazine—Anorexia—Pravastatin—atherosclerosis	0.00169	0.00259	CcSEcCtD
Procarbazine—Hypotension—Niacin—atherosclerosis	0.00169	0.00258	CcSEcCtD
Procarbazine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00169	0.00257	CcSEcCtD
Procarbazine—Constipation—Simvastatin—atherosclerosis	0.00168	0.00257	CcSEcCtD
Procarbazine—Pain—Simvastatin—atherosclerosis	0.00168	0.00257	CcSEcCtD
Procarbazine—Urticaria—Lovastatin—atherosclerosis	0.00167	0.00255	CcSEcCtD
Procarbazine—Body temperature increased—Lovastatin—atherosclerosis	0.00166	0.00254	CcSEcCtD
Procarbazine—Abdominal pain—Lovastatin—atherosclerosis	0.00166	0.00254	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00164	0.00251	CcSEcCtD
Procarbazine—Dizziness—Rosuvastatin—atherosclerosis	0.00164	0.0025	CcSEcCtD
Procarbazine—Urticaria—Ezetimibe—atherosclerosis	0.00164	0.0025	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—ESR1—atherosclerosis	0.00163	0.00515	CbGpPWpGaD
Procarbazine—Insomnia—Niacin—atherosclerosis	0.00163	0.00249	CcSEcCtD
Procarbazine—Abdominal pain—Ezetimibe—atherosclerosis	0.00163	0.00249	CcSEcCtD
Procarbazine—Body temperature increased—Ezetimibe—atherosclerosis	0.00163	0.00249	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—INS—atherosclerosis	0.00162	0.00512	CbGpPWpGaD
Procarbazine—CYP1B1—Biological oxidations—CYP27A1—atherosclerosis	0.00162	0.00511	CbGpPWpGaD
Procarbazine—Paraesthesia—Niacin—atherosclerosis	0.00162	0.00248	CcSEcCtD
Procarbazine—Feeling abnormal—Simvastatin—atherosclerosis	0.00162	0.00247	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00162	0.00247	CcSEcCtD
Procarbazine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00161	0.00245	CcSEcCtD
Procarbazine—Insomnia—Pravastatin—atherosclerosis	0.00161	0.00245	CcSEcCtD
Procarbazine—Somnolence—Niacin—atherosclerosis	0.0016	0.00245	CcSEcCtD
Procarbazine—CYP1B1—Metapathway biotransformation—CYP27A1—atherosclerosis	0.0016	0.00504	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—CCL2—atherosclerosis	0.0016	0.00504	CbGpPWpGaD
Procarbazine—Paraesthesia—Pravastatin—atherosclerosis	0.0016	0.00244	CcSEcCtD
Procarbazine—Decreased appetite—Niacin—atherosclerosis	0.00157	0.0024	CcSEcCtD
Procarbazine—Rash—Rosuvastatin—atherosclerosis	0.00156	0.00239	CcSEcCtD
Procarbazine—Dermatitis—Rosuvastatin—atherosclerosis	0.00156	0.00239	CcSEcCtD
Procarbazine—Urticaria—Simvastatin—atherosclerosis	0.00156	0.00238	CcSEcCtD
Procarbazine—Abdominal pain—Simvastatin—atherosclerosis	0.00155	0.00237	CcSEcCtD
Procarbazine—Body temperature increased—Simvastatin—atherosclerosis	0.00155	0.00237	CcSEcCtD
Procarbazine—Headache—Rosuvastatin—atherosclerosis	0.00155	0.00237	CcSEcCtD
Procarbazine—Hypersensitivity—Lovastatin—atherosclerosis	0.00155	0.00236	CcSEcCtD
Procarbazine—Decreased appetite—Pravastatin—atherosclerosis	0.00155	0.00236	CcSEcCtD
Procarbazine—Pain—Niacin—atherosclerosis	0.00154	0.00236	CcSEcCtD
Procarbazine—Fatigue—Pravastatin—atherosclerosis	0.00153	0.00234	CcSEcCtD
Procarbazine—Pain—Pravastatin—atherosclerosis	0.00152	0.00232	CcSEcCtD
Procarbazine—Constipation—Pravastatin—atherosclerosis	0.00152	0.00232	CcSEcCtD
Procarbazine—Hypersensitivity—Ezetimibe—atherosclerosis	0.00152	0.00232	CcSEcCtD
Procarbazine—Asthenia—Lovastatin—atherosclerosis	0.00151	0.0023	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—SERPINE1—atherosclerosis	0.00149	0.0047	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—ALB—atherosclerosis	0.00149	0.00469	CbGpPWpGaD
Procarbazine—Pruritus—Lovastatin—atherosclerosis	0.00149	0.00227	CcSEcCtD
Procarbazine—Asthenia—Ezetimibe—atherosclerosis	0.00148	0.00226	CcSEcCtD
Procarbazine—Gastrointestinal pain—Niacin—atherosclerosis	0.00148	0.00225	CcSEcCtD
Procarbazine—Nausea—Rosuvastatin—atherosclerosis	0.00147	0.00225	CcSEcCtD
Procarbazine—CYP1B1—Melatonin metabolism and effects—NFKB1—atherosclerosis	0.00147	0.00464	CbGpPWpGaD
Procarbazine—Feeling abnormal—Pravastatin—atherosclerosis	0.00146	0.00224	CcSEcCtD
Procarbazine—Pruritus—Ezetimibe—atherosclerosis	0.00146	0.00223	CcSEcCtD
Procarbazine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00145	0.00222	CcSEcCtD
Procarbazine—Hypersensitivity—Simvastatin—atherosclerosis	0.00145	0.00221	CcSEcCtD
Procarbazine—Diarrhoea—Lovastatin—atherosclerosis	0.00144	0.0022	CcSEcCtD
Procarbazine—Urticaria—Niacin—atherosclerosis	0.00143	0.00219	CcSEcCtD
Procarbazine—Body temperature increased—Niacin—atherosclerosis	0.00143	0.00218	CcSEcCtD
Procarbazine—Abdominal pain—Niacin—atherosclerosis	0.00143	0.00218	CcSEcCtD
Procarbazine—Urticaria—Pravastatin—atherosclerosis	0.00141	0.00216	CcSEcCtD
Procarbazine—Asthenia—Simvastatin—atherosclerosis	0.00141	0.00215	CcSEcCtD
Procarbazine—Diarrhoea—Ezetimibe—atherosclerosis	0.00141	0.00215	CcSEcCtD
Procarbazine—Abdominal pain—Pravastatin—atherosclerosis	0.00141	0.00215	CcSEcCtD
Procarbazine—Body temperature increased—Pravastatin—atherosclerosis	0.00141	0.00215	CcSEcCtD
Procarbazine—Pruritus—Simvastatin—atherosclerosis	0.00139	0.00212	CcSEcCtD
Procarbazine—Dizziness—Lovastatin—atherosclerosis	0.00139	0.00212	CcSEcCtD
Procarbazine—Dizziness—Ezetimibe—atherosclerosis	0.00136	0.00208	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—IFNG—atherosclerosis	0.00136	0.00428	CbGpPWpGaD
Procarbazine—Diarrhoea—Simvastatin—atherosclerosis	0.00135	0.00205	CcSEcCtD
Procarbazine—Vomiting—Lovastatin—atherosclerosis	0.00134	0.00204	CcSEcCtD
Procarbazine—Hypersensitivity—Niacin—atherosclerosis	0.00133	0.00203	CcSEcCtD
Procarbazine—Rash—Lovastatin—atherosclerosis	0.00133	0.00202	CcSEcCtD
Procarbazine—Dermatitis—Lovastatin—atherosclerosis	0.00132	0.00202	CcSEcCtD
Procarbazine—Headache—Lovastatin—atherosclerosis	0.00132	0.00201	CcSEcCtD
Procarbazine—Vomiting—Ezetimibe—atherosclerosis	0.00131	0.002	CcSEcCtD
Procarbazine—Hypersensitivity—Pravastatin—atherosclerosis	0.00131	0.002	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—PTGS2—atherosclerosis	0.0013	0.00411	CbGpPWpGaD
Procarbazine—Dizziness—Simvastatin—atherosclerosis	0.0013	0.00199	CcSEcCtD
Procarbazine—Rash—Ezetimibe—atherosclerosis	0.0013	0.00198	CcSEcCtD
Procarbazine—Dermatitis—Ezetimibe—atherosclerosis	0.0013	0.00198	CcSEcCtD
Procarbazine—Asthenia—Niacin—atherosclerosis	0.0013	0.00198	CcSEcCtD
Procarbazine—Headache—Ezetimibe—atherosclerosis	0.00129	0.00197	CcSEcCtD
Procarbazine—Pruritus—Niacin—atherosclerosis	0.00128	0.00195	CcSEcCtD
Procarbazine—Asthenia—Pravastatin—atherosclerosis	0.00128	0.00195	CcSEcCtD
Procarbazine—Pruritus—Pravastatin—atherosclerosis	0.00126	0.00192	CcSEcCtD
Procarbazine—Vomiting—Simvastatin—atherosclerosis	0.00125	0.00191	CcSEcCtD
Procarbazine—Nausea—Lovastatin—atherosclerosis	0.00125	0.00191	CcSEcCtD
Procarbazine—Rash—Simvastatin—atherosclerosis	0.00124	0.00189	CcSEcCtD
Procarbazine—Dermatitis—Simvastatin—atherosclerosis	0.00124	0.00189	CcSEcCtD
Procarbazine—Diarrhoea—Niacin—atherosclerosis	0.00124	0.00189	CcSEcCtD
Procarbazine—Headache—Simvastatin—atherosclerosis	0.00123	0.00188	CcSEcCtD
Procarbazine—Nausea—Ezetimibe—atherosclerosis	0.00122	0.00187	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IFNG—atherosclerosis	0.00122	0.00386	CbGpPWpGaD
Procarbazine—Diarrhoea—Pravastatin—atherosclerosis	0.00122	0.00186	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—IL1B—atherosclerosis	0.00121	0.00382	CbGpPWpGaD
Procarbazine—Dizziness—Niacin—atherosclerosis	0.00119	0.00182	CcSEcCtD
Procarbazine—Dizziness—Pravastatin—atherosclerosis	0.00118	0.00179	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—atherosclerosis	0.00117	0.0037	CbGpPWpGaD
Procarbazine—Nausea—Simvastatin—atherosclerosis	0.00117	0.00178	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.00115	0.00363	CbGpPWpGaD
Procarbazine—Vomiting—Niacin—atherosclerosis	0.00115	0.00175	CcSEcCtD
Procarbazine—Rash—Niacin—atherosclerosis	0.00114	0.00174	CcSEcCtD
Procarbazine—Dermatitis—Niacin—atherosclerosis	0.00114	0.00174	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—NFKB1—atherosclerosis	0.00113	0.00356	CbGpPWpGaD
Procarbazine—Headache—Niacin—atherosclerosis	0.00113	0.00173	CcSEcCtD
Procarbazine—Vomiting—Pravastatin—atherosclerosis	0.00113	0.00173	CcSEcCtD
Procarbazine—Rash—Pravastatin—atherosclerosis	0.00112	0.00171	CcSEcCtD
Procarbazine—Dermatitis—Pravastatin—atherosclerosis	0.00112	0.00171	CcSEcCtD
Procarbazine—Headache—Pravastatin—atherosclerosis	0.00111	0.0017	CcSEcCtD
Procarbazine—CYP1B1—Arachidonic acid metabolism—PTGS2—atherosclerosis	0.0011	0.00346	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL1B—atherosclerosis	0.00109	0.00344	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.00108	0.00342	CbGpPWpGaD
Procarbazine—Nausea—Niacin—atherosclerosis	0.00107	0.00164	CcSEcCtD
Procarbazine—Ibuprofen—PTGS2—atherosclerosis	0.00107	0.0385	CrCbGaD
Procarbazine—Nausea—Pravastatin—atherosclerosis	0.00106	0.00161	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—NFKB1—atherosclerosis	0.00102	0.00321	CbGpPWpGaD
Procarbazine—XDH—Metabolism—LDLRAP1—atherosclerosis	0.000959	0.00302	CbGpPWpGaD
Procarbazine—Ibuprofen—ALB—atherosclerosis	0.000954	0.0343	CrCbGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.00094	0.00296	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.00094	0.00296	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—atherosclerosis	0.000924	0.00291	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PLTP—atherosclerosis	0.000901	0.00284	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—TNF—atherosclerosis	0.00088	0.00277	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TGFB1—atherosclerosis	0.000848	0.00267	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—atherosclerosis	0.000792	0.0025	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—TNF—atherosclerosis	0.000792	0.0025	CbGpPWpGaD
Procarbazine—XDH—Metabolism—LTA4H—atherosclerosis	0.000782	0.00246	CbGpPWpGaD
Procarbazine—XDH—Metabolism—ABCG8—atherosclerosis	0.000782	0.00246	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000743	0.00234	CbGpPWpGaD
Procarbazine—CYP1B1—Biological oxidations—GSTM1—atherosclerosis	0.000724	0.00228	CbGpPWpGaD
Procarbazine—CYP1B1—Metapathway biotransformation—GSTM1—atherosclerosis	0.000714	0.00225	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—IL6—atherosclerosis	0.00071	0.00224	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000699	0.0022	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000699	0.0022	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.000686	0.00216	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.000674	0.00212	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000623	0.00196	CbGpPWpGaD
Procarbazine—XDH—Metabolism—ABCG1—atherosclerosis	0.000618	0.00195	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.00059	0.00186	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.00059	0.00186	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.00059	0.00186	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.00059	0.00186	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000583	0.00184	CbGpPWpGaD
Procarbazine—XDH—Metabolism—FABP4—atherosclerosis	0.000581	0.00183	CbGpPWpGaD
Procarbazine—XDH—Metabolism—LCAT—atherosclerosis	0.000581	0.00183	CbGpPWpGaD
Procarbazine—XDH—Metabolism—APOA4—atherosclerosis	0.00057	0.0018	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.000563	0.00177	CbGpPWpGaD
Procarbazine—XDH—Metabolism—CYP7A1—atherosclerosis	0.00056	0.00177	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.00054	0.0017	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.00052	0.00164	CbGpPWpGaD
Procarbazine—XDH—Metabolism—CYP27A1—atherosclerosis	0.000518	0.00163	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—LDLRAP1—atherosclerosis	0.000514	0.00162	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.000502	0.00158	CbGpPWpGaD
Procarbazine—XDH—Metabolism—ALOX5AP—atherosclerosis	0.000491	0.00155	CbGpPWpGaD
Procarbazine—XDH—Metabolism—ALOX15—atherosclerosis	0.000491	0.00155	CbGpPWpGaD
Procarbazine—XDH—Metabolism—APOA2—atherosclerosis	0.000491	0.00155	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PLA2G2A—atherosclerosis	0.000491	0.00155	CbGpPWpGaD
Procarbazine—XDH—Metabolism—ABCG5—atherosclerosis	0.000485	0.00153	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PLTP—atherosclerosis	0.000483	0.00152	CbGpPWpGaD
Procarbazine—XDH—Metabolism—LPA—atherosclerosis	0.000468	0.00148	CbGpPWpGaD
Procarbazine—XDH—Metabolism—BGN—atherosclerosis	0.000453	0.00143	CbGpPWpGaD
Procarbazine—XDH—Metabolism—APOA5—atherosclerosis	0.000449	0.00141	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.000447	0.00141	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000445	0.0014	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.000442	0.00139	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PLA2G1B—atherosclerosis	0.000432	0.00136	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.000432	0.00136	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—LTA4H—atherosclerosis	0.000419	0.00132	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ABCG8—atherosclerosis	0.000419	0.00132	CbGpPWpGaD
Procarbazine—XDH—Metabolism—ALOX5—atherosclerosis	0.000417	0.00132	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.000413	0.0013	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.00039	0.00123	CbGpPWpGaD
Procarbazine—XDH—Metabolism—NAMPT—atherosclerosis	0.000374	0.00118	CbGpPWpGaD
Procarbazine—XDH—Metabolism—LIPC—atherosclerosis	0.000372	0.00117	CbGpPWpGaD
Procarbazine—XDH—Metabolism—APOC3—atherosclerosis	0.00037	0.00116	CbGpPWpGaD
Procarbazine—XDH—Metabolism—LDLR—atherosclerosis	0.000367	0.00116	CbGpPWpGaD
Procarbazine—XDH—Metabolism—CETP—atherosclerosis	0.000359	0.00113	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.000348	0.0011	CbGpPWpGaD
Procarbazine—XDH—Metabolism—SCARB1—atherosclerosis	0.000344	0.00108	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ABCG1—atherosclerosis	0.000331	0.00104	CbGpPWpGaD
Procarbazine—XDH—Metabolism—HMGCR—atherosclerosis	0.000325	0.00102	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—LCAT—atherosclerosis	0.000311	0.000981	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—FABP4—atherosclerosis	0.000311	0.000981	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—APOA4—atherosclerosis	0.000305	0.000963	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—CYP7A1—atherosclerosis	0.0003	0.000946	CbGpPWpGaD
Procarbazine—XDH—Metabolism—ABCA1—atherosclerosis	0.000289	0.000912	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.000286	0.000901	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—CYP27A1—atherosclerosis	0.000277	0.000874	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.000273	0.00086	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.000266	0.000839	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ALOX5AP—atherosclerosis	0.000263	0.000829	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—APOA2—atherosclerosis	0.000263	0.000829	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PLA2G2A—atherosclerosis	0.000263	0.000829	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ALOX15—atherosclerosis	0.000263	0.000829	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ABCG5—atherosclerosis	0.00026	0.000818	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.000259	0.000818	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—LPA—atherosclerosis	0.000251	0.00079	CbGpPWpGaD
Procarbazine—XDH—Metabolism—HMOX1—atherosclerosis	0.000248	0.000782	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—BGN—atherosclerosis	0.000243	0.000766	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.000241	0.00076	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—APOA5—atherosclerosis	0.00024	0.000758	CbGpPWpGaD
Procarbazine—XDH—Metabolism—APOB—atherosclerosis	0.000238	0.000749	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.000234	0.000736	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PLA2G1B—atherosclerosis	0.000231	0.000729	CbGpPWpGaD
Procarbazine—XDH—Metabolism—GSTM1—atherosclerosis	0.000231	0.000729	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000229	0.000721	CbGpPWpGaD
Procarbazine—XDH—Metabolism—LPL—atherosclerosis	0.000227	0.000715	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.000227	0.000715	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.000226	0.000713	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ALOX5—atherosclerosis	0.000224	0.000704	CbGpPWpGaD
Procarbazine—XDH—Metabolism—GPX1—atherosclerosis	0.000221	0.000698	CbGpPWpGaD
Procarbazine—XDH—Metabolism—CD36—atherosclerosis	0.000216	0.00068	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000207	0.000651	CbGpPWpGaD
Procarbazine—XDH—Metabolism—MTHFR—atherosclerosis	0.000204	0.000644	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—NAMPT—atherosclerosis	0.0002	0.000632	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PPARA—atherosclerosis	0.0002	0.000632	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.000199	0.000628	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—LIPC—atherosclerosis	0.000199	0.000628	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—APOC3—atherosclerosis	0.000198	0.000624	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—LDLR—atherosclerosis	0.000197	0.00062	CbGpPWpGaD
Procarbazine—XDH—Metabolism—AGT—atherosclerosis	0.000194	0.000612	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—CETP—atherosclerosis	0.000192	0.000606	CbGpPWpGaD
Procarbazine—XDH—Metabolism—APOE—atherosclerosis	0.00019	0.0006	CbGpPWpGaD
Procarbazine—XDH—Metabolism—CAV1—atherosclerosis	0.000188	0.000594	CbGpPWpGaD
Procarbazine—XDH—Metabolism—APOA1—atherosclerosis	0.000188	0.000593	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—SCARB1—atherosclerosis	0.000184	0.00058	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.000179	0.000565	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—HMGCR—atherosclerosis	0.000174	0.000548	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PIK3CG—atherosclerosis	0.000172	0.000541	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PPARG—atherosclerosis	0.000166	0.000522	CbGpPWpGaD
Procarbazine—XDH—Metabolism—INS—atherosclerosis	0.000163	0.000512	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000157	0.000494	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ABCA1—atherosclerosis	0.000155	0.000488	CbGpPWpGaD
Procarbazine—XDH—Metabolism—ALB—atherosclerosis	0.000149	0.00047	CbGpPWpGaD
Procarbazine—XDH—Metabolism—NOS3—atherosclerosis	0.000143	0.000449	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—HMOX1—atherosclerosis	0.000133	0.000419	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PTGS2—atherosclerosis	0.00013	0.000411	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—APOB—atherosclerosis	0.000127	0.000401	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GSTM1—atherosclerosis	0.000124	0.00039	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—LPL—atherosclerosis	0.000122	0.000383	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GPX1—atherosclerosis	0.000119	0.000374	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—CD36—atherosclerosis	0.000116	0.000364	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—MTHFR—atherosclerosis	0.000109	0.000345	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PPARA—atherosclerosis	0.000107	0.000338	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—AGT—atherosclerosis	0.000104	0.000328	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—APOE—atherosclerosis	0.000102	0.000321	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—CAV1—atherosclerosis	0.000101	0.000318	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—APOA1—atherosclerosis	0.000101	0.000318	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PIK3CG—atherosclerosis	9.2e-05	0.00029	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PPARG—atherosclerosis	8.88e-05	0.00028	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—INS—atherosclerosis	8.71e-05	0.000274	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ALB—atherosclerosis	7.98e-05	0.000252	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—NOS3—atherosclerosis	7.63e-05	0.000241	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PTGS2—atherosclerosis	6.98e-05	0.00022	CbGpPWpGaD
Procarbazine—XDH—Metabolism—AKT1—atherosclerosis	6.55e-05	0.000206	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—AKT1—atherosclerosis	3.51e-05	0.000111	CbGpPWpGaD
